Anemia: all 1,768 studies
Page 17 of 18. Open to participants first (244), then studies with results posted, then the rest; newest registration first within each.
- A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in Patients With Anemia as a Result of Advanced Cancer and Treatment With Aggressive ChemotherapyCompletedNCT00266617Phase 2
- Cost-effectiveness Study of Epoetin Alfa and Darbepoetin Alfa in Adult Patients With Cancer Who Have AnemiaCompletedNCT00264108
- A Study to Evaluate the Effect of Weekly PROCRIT (Epoetin Alfa) or Placebo on Anemia and Quality of Life in Children With Cancer Undergoing ChemotherapyCompletedNCT00261677Phase 3
- A Study of the Safety and Efficacy of Long-term Correction of Anemia With Epoetin Alfa in Early Hemodialysis PatientsCompletedNCT00261521Phase 3
- Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for CancerCompletedNCT00255749Phase 2
- A Crossover Safety Study of Ferumoxytol Versus PlaceboCompletedNCT00255450Phase 3
- Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease PatientsCompletedNCT00255437Phase 3
- Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease PatientsCompletedNCT00255424Phase 3
- Treatment of Anemia in the 2nd Year of Life. Comparison of the Efficacy of Two Different Iron Preparations.Status unknownNCT00248716Phase 4
- A Study to Assess the Effectiveness of PROCRIT (Epoetin Alfa) Dosing Every 2 Weeks Versus Once a Week in Anemic HIV-infected PatientsTerminatedNCT00246298Phase 2
- Study of Aranesp to Treat Anemia in Prostate Cancer Patients.CompletedNCT00245895Phase 2
- Oxandrolone for the Treatment of Bone Marrow Aplasia in Fanconi AnemiaCompletedNCT00243399Phase 1
- Treatment of Anemia in Diabetic Subjects With CKDTerminatedNCT00240734Phase 2
- Pharmacokinetic of Intravenous Iron Sucrose in Adolescents on Hemodialysis or Peritoneal Dialysis Receiving EpoetinCompletedNCT00239616Phase 2
- Fractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid MalignanciesCompletedNCT00239239Phase 2
- Cohort Study to Determine the Long-Term Safety and Efficacy of Biogeneric Epoetin Treatment for Renal AnemiaStatus unknownNCT00238043Phase 3
- Comparison of Oral Iron With IV Iron in Patients With Anemia of Chronic Renal Failure Not on DialysisCompletedNCT00236964Phase 3
- Randomized, Double-blind, Placebo-controlled Study to Assess Fatigue in Patients With ACD Due to RA Receiving PROCRITTerminatedNCT00236678Phase 2
- PROCRIT and Short-Term Outcomes in Orthopedic SurgeryTerminatedNCT00236405Phase 2
- Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Hemodialysis PatientsCompletedNCT00233597Phase 3
- A Phase II Study to Assess Changes in Physical Function in Elderly Patients With Chronic AnemiaTerminatedNCT00228995Phase 2
- Peginesatide for Anemia in Chronic Hemodialysis PatientsCompletedNCT00228449Phase 2
- Safety, PD & PK of Multiple Doses of Peginesatide for Anemia in Chronic Kidney Disease PatientsCompletedNCT00228436Phase 2
- Effect of Iron Therapy as an Adjunct to Epoetin Alfa in the Anemia of Cancer ChemotherapyCompletedNCT00224068Phase 4
- A Study of the Safety and Effectiveness of Epoetin Alfa on Hemoglobin Levels and Blood Transfusions in Cancer Patients Receiving ChemotherapyCompletedNCT00216541Phase 4
- Darbepoetin Treatment of Anemia in Children With Chronic Renal FailureCompletedNCT00213291Phase 3
- Using Iron Supplementation to Decrease Iron Deficiency Anemia in Infants and Young Children in IndiaCompletedNCT00213161Not applicable
- A Study of Four Dosing Regimens of PROCRIT (Epoetin Alfa) in Patients With Chronic Kidney Disease. Protocol Addendum: Extension Study of Maintenance Therapy of PROCRIT (Epoetin Alfa) in Patients With Chronic Kidney Disease.CompletedNCT00212875Phase 2
- Dosing and Outcomes Study of Erythropoietic Stimulating Therapies in Patients With Chemotherapy Induced AnemiaCompletedNCT00212862
- A Study to Observe the Causes and Treatment of Anemia in Critically Ill ChildrenCompletedNCT00211055
- A Study of Patients Treated With Erythropoietin Receptor Agonists for Anemia Who Developed Anti-erythropoietin AntibodiesWithdrawnNCT00210977
- A Phase II Study to Assess Changes in Physical Function in Elderly Patients With Chronic AnemiaTerminatedNCT00210795Phase 2
- Alternate Dosing - Initiation of Every 2 Week Epoetin Alfa (PROCRIT) in the Treatment of Anemia.CompletedNCT00210743Phase 2
- The Duration StudyTerminatedNCT00210730Phase 3
- Early and Standard Intervention With 120,000 Units of PROCRIT (Epoetin Alfa) Every Three Weeks in Patients Receiving ChemotherapyCompletedNCT00210600Phase 2
- An Efficacy and Safety Study for Epoetin Alfa (PROCRIT) in Cancer Patients Not Receiving Chemotherapy or RadiationCompletedNCT00210587Phase 3
- Feasibility and Effectiveness of Distributing Micronutrient Sprinkles to Reduce Prevalence of AnemiaCompletedNCT00210405Not applicable
- Evaluation of Iron Supplementation During Darbepoetin Alfa Treatment in Prophylaxis of Severe Anaemia Chemo-InducedTerminatedNCT00210002Phase 2
- Iron Supplementation Among Low-Income Postpartum WomenCompletedNCT00207610Phase 3
- Effects of Anemia Correction on Vascular and Monocyte Function in Renal Transplant RecipientsCompletedNCT00204334Phase 4
- Iron Therapy in Colo-Rectal Neoplasm and Iron Deficiency Anemia: Intravenous Iron Sucrose Versus Oral Ferrous Sulphate.Status unknownNCT00199277Phase 4
- Treatment of Anemia and Neutropenia in HIV/HCV Coinfected Patients Treated With Pegylated Interferon and RibavirinTerminatedNCT00194857Phase 4
- Purified CD34+ Hematopoietic Stem Cell Transplantation From Alternate Donors for Patients With Severe Aplastic AnemiaCompletedNCT00186797Not applicable
- The Community Effectiveness of IPTi in Southern TanzaniaStatus unknownNCT00152204Phase 3
- Treatment and Prevention of Severe Anemia in Pregnant Zanzibari WomenCompletedNCT00148629Phase 3
- Study for the Treatment of Anemia in Patients With Non-myeloid Malignancies Receiving Multicycle Chemotherapy.CompletedNCT00148421Phase 3
- Efficacy of Epoetin Alfa Deep Tank in Treatment of Anemia in Patients With Chronic Kidney Disease Receiving HemodialysisCompletedNCT00146224Phase 3
- Conditioning Regimens for Patients With Severe Aplastic Anemia Transplanted With Marrow From an Unrelated DonorCompletedNCT00144729Phase 1/2
- Flexibility: A Study to Assess the Impact of Darbepoetin Alfa in Subjects withNon-Myeloid Malignancies With Anemia Due to ChemotherapyCompletedNCT00144131Phase 2
- Study of the Impact of Intermittent Preventive Treatment in Schools on Malaria, Anaemia and Education.CompletedNCT00142246Phase 3
- Prevention of Severe Anaemia in Gambian ChildrenCompletedNCT00131716Phase 3
- Open-Label Extension Safety Study of PROCRIT in Patients With Anemia of Chronic Disease Due to Rheumatoid ArthritisWithdrawnNCT00123149Phase 2
- Efficacy Study: Darbepoetin Alfa for the Treatment of Anemia in Patients With Chronic Kidney DiseaseCompletedNCT00121602Phase 3
- Treatment for Patients With Gynecological Malignancies Who Suffer From Anemia Due to ChemotherapyCompletedNCT00121030Phase 2
- Treatment for Patients Suffering From Anemia Due to ChemotherapyCompletedNCT00120692Phase 2
- Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to ChemotherapyCompletedNCT00120679Phase 2
- A Study of AMG 114 Administered by Subcutaneous Injection for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies Receiving Multicycle ChemotherapyTerminatedNCT00119600Phase 1/2
- Darbepoetin Alfa Treatment of Anemia in Hemodialysis SubjectsCompletedNCT00119587Phase 3
- A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle ChemotherapyCompletedNCT00118638Phase 3
- A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With a Non-Myeloid MalignancyCompletedNCT00117624Phase 3
- A Study of Repeat-Dose Subcutaneous Darbepoetin Alfa in Subjects With Congestive Heart Failure and Anemia, and a Single Dose in Healthy Age- and Sex-Matched Control SubjectsCompletedNCT00117247Phase 1/2
- Impact of Darbepoetin Alfa on Exercise Tolerance and Left Ventricular Structure in Subjects With Symptomatic Congestive Heart Failure (CHF) and AnemiaCompletedNCT00117234Not applicable
- A Study to Assess Symptom Burden in Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Aranesp®CompletedNCT00117117Phase 4
- Study of Transplant Related Anemia Treated With Aranesp® (STRATA)CompletedNCT00117065Phase 4
- A Study to Evaluate the Effectiveness of Aranesp® for Cancer Patients With AnemiaCompletedNCT00117039Phase 4
- Severe Anemia Treatment Trials, PakistanCompletedNCT00116493Phase 3
- A Study of Darbepoetin Alfa in Anemic Subjects Not Receiving Chemotherapy Who Have Completed the 20010103 StudyCompletedNCT00115167Phase 3
- Heart Disease in Sickle Cell AnemiaCompletedNCT00113152
- Evaluating Aranesp® for the Treatment of Anemia in African-American Subjects With Chronic Renal Failure (CRF) Receiving HemodialysisCompletedNCT00111995Phase 4
- Evaluating Treatment of Anemia in Subjects With Non-Myeloid MalignanciesReceiving Multicycle ChemotherapyCompletedNCT00111462Phase 2
- Intermittent Preventive Treatment With Antimalarials in Kenyan InfantsCompletedNCT00111163Not applicable
- Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle ChemotherapyCompletedNCT00110955Phase 3
- Lenalidomide in Treating Young Patients With Relapsed or Refractory Solid Tumors or Myelodysplastic SyndromesCompletedNCT00104962Phase 1
- Idiopathic Anemia of Aging (IAA)TerminatedNCT00104169Phase 2
- SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic SyndromesCompletedNCT00098826Phase 1
- Study Evaluating Darbepoetin Alfa in Subjects With Chronic Kidney Disease (CKD) Receiving DialysisCompletedNCT00096915Phase 3
- XK469R in Treating Patients With Refractory Hematologic CancerCompletedNCT00095797Phase 1
- Darbepoetin Alfa Administered Once Every 4 Weeks in the Treatment of Subjects With Anemia of CancerCompletedNCT00095277Phase 2
- Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed by Unrelated Donor Stem Cell Transplant in Treating Patients With Fanconi AnemiaCompletedNCT00093743Phase 1
- Research Into the Treatment of Anemia for Critically Ill Patients Admitted to Intensive Care Units (ICU)CompletedNCT00091910Phase 3
- Study of Darbepoetin Alfa for the Treatment of Anemia of CancerCompletedNCT00091858Phase 3
- Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous LeukemiaCompletedNCT00087204Phase 1
- Subcutaneous (SC) Darbepoetin Alfa in Subjects With Symptomatic Congestive Heart Failure (CHF) & AnemiaCompletedNCT00086086Phase 2
- CCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic PhaseCompletedNCT00084916Phase 2
- Treatment of Anemia in Patients With Cancer Who Are Not Currently Receiving Chemotherapy or RadiotherapyTerminatedNCT00083486Phase 3
- Treatment of Anemic Patients With Cancer Who Are Not Receiving Chemotherapy or RadiotherapyTerminatedNCT00083434Phase 3
- A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis PatientsCompletedNCT00081484Phase 3
- A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on DialysisCompletedNCT00081471Phase 3
- Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell TransplantCompletedNCT00078858Phase 1/2
- A Study of Mircera for the Treatment of Anemia in Dialysis PatientsCompletedNCT00077597Phase 3
- Ro 50-3821 in Treating Anemia in Patients Receiving Antineoplastic Therapy for Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00072059Phase 2
- Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for CancerCompletedNCT00070382Phase 3
- Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic AnemiasCompletedNCT00061763Phase 2
- Improving Immunosuppressive Treatment for Patients With Severe Aplastic AnemiaCompletedNCT00061360Phase 2
- Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate CancerCompletedNCT00060398Phase 3
- Epoetin Alfa in Treating Anemia in Patients With Solid TumorsCompletedNCT00058331Phase 3
- Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic AnemiaCompletedNCT00054236Phase 1
- Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic SyndromeCompletedNCT00053001Phase 2
- Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell TransplantationCompletedNCT00052520Phase 1/2
- Collection of Biological Samples From Patients With Hepatitis-Associated Aplastic AnemiaCompletedNCT00050115